Novartis has signed an agreement for the acquisition of all outstanding shares of US-based Avidity Biosciences for $12bn in cash on a fully diluted basis.…
GSK had announced that it has entered a definitive agreement to acquire RAPT Therapeutics , a California-based, clinical-stage biopharmaceutical company dedicated to developing novel therapies…
Eli Lilly and Company and Ventyx Biosciences, a San Diego-based clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammatory-mediated diseases, today…
Amgen had announced its acquisition of Dark Blue Therapeutics Ltd., a privately held biotechnology company based in the United Kingdom advancing first-in-class, small molecule-targeted protein…
Pfizer today announced the successful completion of its acquisition of Metsera, a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic…
